Related Experiment Video
Updated: Jun 9, 2026

Methods to Discover Alternative Promoter Usage and Transcriptional Regulation of Murine Bcrp1
Published on: May 27, 2016
Structure and function of the human breast cancer resistance protein (BCRP/ABCG2)
Zhanglin Ni1, Zsolt Bikadi, Mark F Rosenberg
1Department of Pharmaceutics, School of Pharmacy, University of Washington, Health Science Building H272, 1959 NE Pacific Street, Seattle, Washington 98195-7610, USA.
Abstract:
The human breast cancer resistance protein (BCRP/ABCG2) is the second member of the G subfamily of the large ATP-binding cassette (ABC) transporter superfamily. BCRP was initially discovered in multidrug resistant breast cancer cell lines where it confers resistance to chemotherapeutic agents such as mitoxantrone, topotecan and methotrexate by extruding these compounds out of the cell. BCRP is capable of transporting non-chemotherapy drugs and xenobiotiocs as well, including nitrofurantoin, prazosin, glyburide, and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. BCRP is frequently detected at high levels in stem cells, likely providing xenobiotic protection. BCRP is also highly expressed in normal human tissues including the small intestine, liver, brain endothelium, and placenta. Therefore, BCRP has been increasingly recognized for its important role in the absorption, elimination, and tissue distribution of drugs and xenobiotics. At present, little is known about the transport mechanism of BCRP, particularly how it recognizes and transports a large number of structurally and chemically unrelated drugs and xenobiotics. Here, we review current knowledge of structure and function of this medically important ABC efflux drug transporter.
Insights
The breast cancer resistance protein (BCRP/ABCG2) is an ABC transporter that expels drugs from cells. This review covers BCRP
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- The human breast cancer resistance protein (BCRP/ABCG2) is an ATP-binding cassette transporter.
- BCRP confers resistance to chemotherapy drugs by extruding them from cells.
- It also transports various xenobiotics and is found in stem cells and normal tissues.
Purpose of the Study:
- To review the current knowledge of the structure and function of BCRP/ABCG2.
- To highlight BCRP's role in drug absorption, elimination, and distribution.
- To discuss the challenges in understanding BCRP's transport mechanism for diverse substrates.
Main Methods:
- Literature review of existing studies on BCRP/ABCG2.
- Analysis of BCRP's known substrates and tissue expression.
- Discussion of structure-function relationships and transport mechanisms.
Main Results:
- BCRP is a significant efflux transporter involved in multidrug resistance.
- It plays a crucial role in the pharmacokinetics of various drugs and xenobiotics.
- BCRP's broad substrate specificity and transport mechanism remain areas of active research.
Conclusions:
- BCRP/ABCG2 is a medically important transporter with implications in cancer therapy and drug disposition.
- Further research into its structure and mechanism is needed to understand its broad substrate recognition.
- Understanding BCRP function is key to optimizing drug efficacy and minimizing toxicity.
Related Concept Videos
Diversity of Antigen Receptors
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
ABC Transporters: Exporter
Mitogens and the Cell Cycle
Abnormal Proliferation
ABC Transporters: Importer
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
Targeted Cancer Therapies
There are several types of targeted therapies against specific...

